218 related articles for article (PubMed ID: 17450141)
1. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.
Sun T; Gao Y; Tan W; Ma S; Shi Y; Yao J; Guo Y; Yang M; Zhang X; Zhang Q; Zeng C; Lin D
Nat Genet; 2007 May; 39(5):605-13. PubMed ID: 17450141
[TBL] [Abstract][Full Text] [Related]
2. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
4. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.
Wang M; Zhang Z; Tian Y; Shao J; Zhang Z
Clin Cancer Res; 2009 Apr; 15(7):2567-72. PubMed ID: 19276244
[TBL] [Abstract][Full Text] [Related]
5. The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study.
Frank B; Rigas SH; Bermejo JL; Wiestler M; Wagner K; Hemminki K; Reed MW; Sutter C; Wappenschmidt B; Balasubramanian SP; Meindl A; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Justenhoven C; Ko YD; Brüning T; Brauch H; Hamann U; Pharoah PP; Dunning AM; Pooley KA; Easton DF; Cox A; Burwinkel B
Breast Cancer Res Treat; 2008 Sep; 111(1):139-44. PubMed ID: 17891485
[TBL] [Abstract][Full Text] [Related]
6. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
[TBL] [Abstract][Full Text] [Related]
8. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
10. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Lin WY; Camp NJ; Ghoussaini M; Beesley J; Michailidou K; Hopper JL; Apicella C; Southey MC; Stone J; Schmidt MK; Broeks A; Van't Veer LJ; Th Rutgers EJ; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Peto J; Dos-Santos-Silva I; Fletcher O; Johnson N; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Cheng T; Tomlinson I; Kerin MJ; Miller N; Marmé F; Surowy HM; Burwinkel B; Guénel P; Truong T; Menegaux F; Mulot C; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; González-Neira A; Pita G; Alonso MR; Alvarez N; Herrero D; Anton-Culver H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Müller-Myhsok B; Brauch H; Brüning T; Ko YD; ; Tessier DC; Vincent D; Bacot F; Nevanlinna H; Aittomäki K; Blomqvist C; Khan S; Matsuo K; Ito H; Iwata H; Horio A; Bogdanova NV; Antonenkova NN; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Neven P; Wauters E; Wildiers H; Lambrechts D; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Bonanni B; Couch FJ; Wang X; Vachon C; Purrington K; Giles GG; Milne RL; Mclean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Hassan N; Vithana EN; Kristensen V; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Lissowska J; Brinton L; Czene K; Darabi H; Eriksson M; Brand JS; Hooning MJ; Hollestelle A; Van Den Ouweland AM; Jager A; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Perkins B; Shah M; Blows FM; Kang D; Yoo KY; Noh DY; Hartman M; Miao H; Chia KS; Putti TC; Hamann U; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; Mckay J; Slager S; Toland AE; Yannoukakos D; Shen CY; Hsiung CN; Wu PE; Ding SL; Ashworth A; Jones M; Orr N; Swerdlow AJ; Tsimiklis H; Makalic E; Schmidt DF; Bui QM; Chanock SJ; Hunter DJ; Hein R; Dahmen N; Beckmann L; Aaltonen K; Muranen TA; Heikkinen T; Irwanto A; Rahman N; Turnbull CA; ; Waisfisz Q; Meijers-Heijboer HE; Adank MA; Van Der Luijt RB; Hall P; Chenevix-Trench G; Dunning A; Easton DF; Cox A
Hum Mol Genet; 2015 Jan; 24(1):285-98. PubMed ID: 25168388
[TBL] [Abstract][Full Text] [Related]
12. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
13. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with risk of coal workers' pneumoconiosis.
Ni C; Ye Y; Wang M; Qian H; Song Z; Jia X; Zhou J
J Toxicol Environ Health A; 2009; 72(11-12):712-6. PubMed ID: 19492233
[TBL] [Abstract][Full Text] [Related]
14. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
15. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
[TBL] [Abstract][Full Text] [Related]
16. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Engel C; Versmold B; Wappenschmidt B; Simard J; Easton DF; Peock S; Cook M; Oliver C; Frost D; Mayes R; Evans DG; Eeles R; Paterson J; Brewer C; ; McGuffog L; Antoniou AC; Stoppa-Lyonnet D; Sinilnikova OM; Barjhoux L; Frenay M; Michel C; Leroux D; Dreyfus H; Toulas C; Gladieff L; Uhrhammer N; Bignon YJ; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Preisler-Adams S; Kast K; Deissler H; Sutter C; Gadzicki D; Chenevix-Trench G; Spurdle AB; Chen X; Beesley J; ; Olsson H; Kristoffersson U; Ehrencrona H; Liljegren A; ; van der Luijt RB; van Os TA; van Leeuwen FE; ; Domchek SM; Rebbeck TR; Nathanson KL; Osorio A; Ramón y Cajal T; Konstantopoulou I; Benítez J; Friedman E; Kaufman B; Laitman Y; Mai PL; Greene MH; Nevanlinna H; Aittomäki K; Szabo CI; Caldes T; Couch FJ; Andrulis IL; Godwin AK; Hamann U; Schmutzler RK;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2859-68. PubMed ID: 20978178
[TBL] [Abstract][Full Text] [Related]
17. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
[TBL] [Abstract][Full Text] [Related]
18. The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population.
Liu SG; Yuan SH; Wu HY; Huang CS; Liu J
Tumour Biol; 2014 Sep; 35(9):8679-83. PubMed ID: 24870593
[TBL] [Abstract][Full Text] [Related]
19. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
20. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.
Wang M; Zhang Z; Zhu H; Fu G; Wang S; Wu D; Zhou J; Wei Q; Zhang Z
Clin Cancer Res; 2008 Jun; 14(11):3633-40. PubMed ID: 18519798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
